GMO Ultra-Short Income ETF (GMOC) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
GMO Ultra-Short Income ETF (GMOC) operates in the Financial Services sector, specifically the Asset Management - Bonds industry, with a market capitalization near $1.3M, listed on AMEX, carrying a beta of 0.02 to the broader market. GMOC curates a low-duration fixed income portfolio composed of US Treasuries, CLOs, repurchase and reverse repurchase agreements, and other investment-grade securities. Led by Tracey Keenan, public since 2025-10-24.
Max pain analysis shows the strike price where the most options expire worthless. No recent options activity for GMOC as of 2026-06-01; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.